PrintThe Burrill Report
The Burrill Report (December 30, 2013): Fighting Cancer with Gene Therapy (.MP3,12.26 Mb)
Though great strides have been made in the development of cancer therapeutics, conventional approaches to treating the disease have limited benefits and often come with serious side effects. One area of great promise to change the paradigm for treating cancer is in the rapidly evolving area of immunotherapies that harness the body’s own immune system to fight cancer. We spoke to Harry Gruber, CEO of privately held Tocagen, about his company’s early-stage experimental gene therapy, why these approaches provide promise, and how the environment for these types of therapies is changing.
December 26, 2013
http://www.burrillreport.com/article-fighting_cancer_with_gene_therapy.html
GENE THERAPY
Fighting Cancer with Gene Therapy
Podcast: December 30, 2013[Please login to post comments]
- Global Life Sciences M&A; Deal Values Hit $131.8B in 2013
Big Pharma takes a breather from M&A.; Read More - Asia’s Share of Biomedical R&D; Investment Grows
With lure of lower cost labor and subsidies, industry appears to be shifting investments East. Read More - Drugmakers Launch Data-sharing Site
New patient-level data will open avenues for further research of approved medicines. Read More - A Look at 2013, the J.P. Morgan Conference, and Beyond
Podcast: January 6, 2014 Read More - FDA Rebuffs Genzyme’s Lemtrada for Relapsing MS
The weekly round-up of failed trials, missed targets, and other business mishaps. Read More - Banner Year for Life Sciences IPOs
More than three quarters of the 52 companies that went public ended the year above their initial offering price. Read More - Buyout Firm Acquires Majority Stake in Ikaria
Critical therapy company will pursue international expansion while spinning out part of pipeline. Read More - Tesaro Reports Positive Results, but Not Good Enough as Investors Sink Shares
The weekly round-up of failed trials, missed targets, and other business mishaps. Read More - Alzheimer’s Disease Unraveled
Researchers clarify where it starts, why it starts there, and how it spreads. Read More - Merck Launches New Weight Management Business
Partnership with Health Management Resources seeks to lower healthcare costs, minimize chronic disease risks. Read More
.gif)
